Zithromax is a U.S. brand of azithromycin, a prescription macrolide antibiotic. The brand name spans multiple oral product presentations rather than a single universal package. A pharmacy listing for “Zithromax” can therefore refer to an ordinary-strength tablet, an oral suspension or a branded course package, and those distinctions are important when reviewing the written prescription.
The manufacturer’s product labeling describes 250 mg and 500 mg oral tablets, oral-suspension preparations and branded unit-dose packaging such as Z-Pak and Tri-Pak. These packages have specific tablet counts; neither name tells a patient that a particular regimen is appropriate for an illness.
This page is a brand-family reference, not a claim that every historic or labeled presentation can be ordered from any pharmacy today. Review the precise formulation on the prescription and the pharmacy’s actual dispensing offer. For a product-by-product approval and substitution discussion see the comparison with approved generics.
Pfizer-associated Zithromax labeling is the reference point for the brand’s approved U.S. oral products. The name alone omits tablet strength, concentration, package size and intended use. A patient seeking to identify a label should confirm the full product descriptor rather than relying on the brand word.
A Zithromax search result that references injectable azithromycin or ophthalmic azithromycin is not describing the same oral presentation. For the separate azithromycin eye product, consult AzaSite’s ophthalmic-specific guide.
| Brand family item | Product identity | Separate question to resolve |
|---|---|---|
| Zithromax tablet | Oral 250 mg or 500 mg unit strength | Quantity and directions |
| Z-Pak | Six 250 mg tablets in branded pack | Is the five-day pack specifically prescribed? |
| Tri-Pak | Three 500 mg tablets in branded pack | Is the three-day presentation specifically prescribed? |
| Zithromax suspension | 100 or 200 mg/5 mL after reconstitution | Concentration, volume and mixing instructions |
U.S. brand labeling describes Zithromax tablets containing the equivalent of 250 mg or 500 mg azithromycin. Packaging may include larger stock bottles and purpose-designed blister configurations. The printed milligrams identify an individual tablet, not a treatment choice.
Read the tablet-form overview when comparing ordinary pill presentations. Strength-specific pages go into product identity, while this brand hub keeps the emphasis on the Pfizer family.
A Z-Pak presentation groups six 250 mg tablets as a labeled five-day pack. A Tri-Pak presentation groups three 500 mg tablets as a labeled three-day pack. These are distinct brand package identifiers even though both use oral azithromycin.
The detailed packaging side-by-side comparison explains why equal-looking total amounts of active drug do not prove interchangeable prescribed schedules.
Zithromax oral suspension is a powder supplied for reconstitution. Product labeling includes 100 mg/5 mL and 200 mg/5 mL concentrations after mixing. The specific bottle’s azithromycin content and the final measured volume are separate fields.
The suspension product guide covers the practical label checks unique to liquid medicine, including the distinction between dry powder and reconstituted liquid.
Official labeling describes approved presentations and their instructions; it is not a live stock feed from U.S. pharmacies. An NDC identifies a specific labeled package, but a matching NDC in a directory does not mean a nearby pharmacy currently dispenses it.
For a branded request, call the pharmacy with the exact form and strength. Ask whether it can supply the prescribed item or whether the prescriber and pharmacist should review an FDA-approved alternative.
Zithromax is not a treatment for viruses. Labeling warns about serious adverse effects and relevant risk factors, including certain cardiac rhythm concerns and possible interactions. A brand name does not make a product preferable when the medicine itself is not clinically indicated.
For targeted risk questions follow the drug-interaction review or the QT-risk discussion instead of using packaging as medical guidance.
A clear prescription should enable the pharmacy to determine the active medicine, formulation, strength or concentration, quantity and directions. If the prescription says only a brand shorthand, the pharmacy may need clarification before dispensing.
When someone requests “the Z-Pak” without any evaluation, a licensed clinician should decide whether azithromycin is appropriate. The prescription pathway explains documentation and pharmacy processing.
The patient-paid amount for a brand tablet bottle may differ from a Z-Pak package or from a matching generic, even when the active drug is azithromycin. Insurance tiers and pharmacy contracts add further variation.
A useful price inquiry names the exact Pfizer presentation. For a brand-specific packaged cost discussion see Z-Pak price factors rather than treating every Zithromax item as a six-tablet pack.
Zithromax is a brand name for azithromycin; verify the exact branded formulation.
No. The brand also covers conventional tablets, Tri-Pak and oral suspension.
No. They identify different tablet strengths, counts and labeled courses.
No. It is a prescription antibacterial medication.
No. Ask the pharmacy to verify its actual inventory and ordering ability.
An FDA-approved therapeutically equivalent product may be dispensed when prescription instructions and substitution rules allow.
No. Azithromycin does not treat viral infections.